MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
54.54
+0.38 (0.70%)
Oct 29, 2026, 4:00 PM EDT - Market closed
MBX Biosciences Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, MBX Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $95.7. The average 1-year stock price forecast is 75.47% higher than the current stock price, while the lowest is $80 (+46.68%) and the highest is $150 (+175.03%).
Price Target: $95.7 (+75.47%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for MBX Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 8 | 8 |
| Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 11 | 12 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $88 | Buy | Maintains | $88 | +61.35% | Oct 13, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $150 | Buy | Reiterates | $150 | +175.03% | Oct 12, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $70 → $84 | Buy | Reiterates | $70 → $84 | +54.02% | Oct 12, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Initiates $88 | Buy | Initiates | $88 | +61.35% | Aug 21, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $70 → $88 | Buy | Maintains | $70 → $88 | +61.35% | Aug 10, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.05
from -2.38
EPS Next Year
-3.98
from -3.05
EPS and Forward PE are based on non-GAAP adjusted numbers.